ReviewPatient related outcome measures2023
Impact of Ravulizumab on Patient Outcomes and Quality of Life in Generalized Myasthenia Gravis.
Carlo Antozzi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it